Delete search term

To content

Main navigation

Zurich University
of Applied Sciences

Service navigation

Developing novel and effective therapies for treatment of childhood brain cancers

Description

Brain cancers are a leading cause of mortality in children. Brainstem glioma constitutes 10% of all pediatric central nervous system tumors, the most common type being a high grade diffuse midline glioma (DMG). Preclinical discoveries fail to translate into clinical success due to: i) drug systemic toxicity, and ii) lack of drug penetration into the brain/tumor. This Innosuisse funded project aims to engineer novel drugs with increased clinical efficacy. To this end, we will design, synthesize and validate anticancer therapeutics that specifically penetrate the blood-brain barrier (BBB). This precision medicine approach will not only increase BBB penetration, but also provide targeted drug delivery, thereby reducing systemic toxicity. Our goal is to develop novel treatment options for childhood brain tumors for which there is currently no cure.

Key data

Project team

Project partners

Kinderspital Zürich - Eleonorenstiftung / DMG Research Center

Project status

completed, 03/2022 - 08/2023

Institute/Centre

Institute of Chemistry and Biotechnology (ICBT)

Funding partner

Innovationsprojekt / Projekt Nr. 59514.1 IP-LS

Privacy Settings

Here we show you which services may run on our website. You decide for yourself which services we may use. You can find more information in our privacy notice.

Our website needs these cookies so that everything works properly. These cookies are created automatically when you are active on the site – for example, when you change privacy settings or fill in forms. You can block these cookies in your browser or set it to warn you about them, but some parts of the website will then no longer display correctly. These cookies do not store any of your personal data.

These services allow us to see how our website is used, but we do not know who you are. By activating these services, you help us make the website better for everyone.